Priority Date: 09.08.12 (US 201261681586P)

CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE

  • Application ID: EP13827396
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

operating since 1884
Headquarter in Birmingham and 5 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Forresters IP LLP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 171 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 09.08.2012 - Priority Date (US 201261681586P)
  • 13.02.2014 - Publication A1 (WO2014026053)
  • 17.06.2015 - Publication A1 (EP2882460)

IPC Classification